We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX (IEX) Q4 Earnings Surpass Estimates, Revenues Down Y/Y
Read MoreHide Full Article
IDEX Corporation’s (IEX - Free Report) fourth-quarter 2023 adjusted earnings of $1.83 per share surpassed the Zacks Consensus Estimate of adjusted earnings of $1.78. On a year-over-year basis, the bottom line decreased approximately 9% from the year-ago quarter’s figure of earnings of $2.01 per share due to the higher effective tax rate. It also exceeded management’s projection of $1.74-$1.79 per share.
Revenue Details
In the quarter under review, IDEX’s net sales of $788.9 million outperformed the Zacks Consensus Estimate of $769 million. However, the top line decreased 3% year over year. Organic sales in the quarter decreased 6% year over year, lower than the 8-9% decline expected by the company. Acquisitions/divestitures boosted sales by 3%.
IEX reports net sales under three business segments, the results of which are discussed below:
Revenues from the Fluid & Metering Technologies segment totaled $299.1 million, increasing 3.9% year over year. Our estimate for segmental revenues was $282.2 million. Organic sales were up 3%. Foreign currency translation left a positive impact of 1%.
Revenues from the Health & Science Technologies segment totaled $312.7 million, indicating a year-over-year decline of 11%. Our estimate for segmental revenues was $309.8 million. Organic sales in the quarter declined 19% year over year, while acquired assets boosted sales by 7%. Foreign currency translation left a positive impact of 1%.
Revenues from the Fire & Safety/Diversified Products segment totaled $179 million, rising 5% year over year. Our estimate for segmental revenues was $175.2 million. The results were aided by a 3% increase in organic sales. Foreign currency translation left a positive impact of 2%.
IDEX Corporation Price, Consensus and EPS Surprise
In the quarter under review, IDEX’s cost of sales decreased 2.8% year over year to $452.1 million. The gross profit was $336.8 million, down 2.6% year over year, while the gross margin was 42.7% compared with 42.6% reported in the year-ago quarter.
Selling, general and administrative expenses increased 2.7% year over year to $173.6 million. Adjusted EBITDA in the quarter under review decreased 7% year over year to $203.6 million. The adjusted EBITDA margin decreased 120 bps year over year to 25.8%.
The operating income was $160.5 million, down 8.3% year over year, whereas the margin was 20.3%, down 130 bps year over year. Interest expenses in the quarter decreased 4.1% year over year to $11.6 million.
Balance Sheet and Cash Flow
While exiting the fourth quarter, IDEX’s cash and cash equivalents were $534.3 million compared with $430.2 million recorded at the end of fourth-quarter 2022. Long-term borrowings were $1.33 billion compared with $1.47 billion recorded at the end of fourth-quarter 2022.
In 2023, IDEX generated net cash of $716.7 million from operating activities, increasing 28.6% from the year-ago period. Capital used for purchasing property, plant and equipment was $89.9 million compared with $68 million in 2022. In 2023, free cash flow was $626.8 million, up 28% year over year.
IEX paid out dividends totaling $190.7 million in 2023, up 7.5% year over year. The company repurchased common stock worth $24.2 million in the quarter.
It spent $311.8 million on acquisitions in 2023.
Outlook
For first-quarter 2024, IDEX anticipates adjusted earnings to be $1.70-$1.75 per share.
On a GAAP basis, IEX predicts earnings to be $1.45-$1.50 per share and a 6-7% decline in organic sales from the respective year-ago readings.
For 2024, IDEX anticipates adjusted earnings to be $8.15-$8.45 per share. The figure represents an increase from $8.22 per share reported in 2023. On a GAAP basis, earnings are predicted to be $7.15-$7.45 per share.
Organic sales are predicted to decline 0-2% in 2024.
Zacks Rank & Other Stocks to Consider
IDEX currently carries a Zacks Rank #2 (Buy).
A few other top-ranked companies from the same space are discussed below:
PH delivered a trailing four-quarter average earnings surprise of 14.4%. In the past 60 days, the Zacks Consensus Estimate for its 2023 earnings has increased 2.7%.
Flowserve Corporation (FLS - Free Report) presently has a Zacks Rank of 2. FLS delivered a trailing four-quarter average earnings surprise of 27.3%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2023 earnings has remained steady.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank #2. It has a trailing four-quarter average earnings surprise of 10.4%. The Zacks Consensus Estimate for AIT’s fiscal 2024 (ending June 2024) earnings remained steady in the past 60 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IDEX (IEX) Q4 Earnings Surpass Estimates, Revenues Down Y/Y
IDEX Corporation’s (IEX - Free Report) fourth-quarter 2023 adjusted earnings of $1.83 per share surpassed the Zacks Consensus Estimate of adjusted earnings of $1.78. On a year-over-year basis, the bottom line decreased approximately 9% from the year-ago quarter’s figure of earnings of $2.01 per share due to the higher effective tax rate. It also exceeded management’s projection of $1.74-$1.79 per share.
Revenue Details
In the quarter under review, IDEX’s net sales of $788.9 million outperformed the Zacks Consensus Estimate of $769 million. However, the top line decreased 3% year over year. Organic sales in the quarter decreased 6% year over year, lower than the 8-9% decline expected by the company. Acquisitions/divestitures boosted sales by 3%.
IEX reports net sales under three business segments, the results of which are discussed below:
Revenues from the Fluid & Metering Technologies segment totaled $299.1 million, increasing 3.9% year over year. Our estimate for segmental revenues was $282.2 million. Organic sales were up 3%. Foreign currency translation left a positive impact of 1%.
Revenues from the Health & Science Technologies segment totaled $312.7 million, indicating a year-over-year decline of 11%. Our estimate for segmental revenues was $309.8 million. Organic sales in the quarter declined 19% year over year, while acquired assets boosted sales by 7%. Foreign currency translation left a positive impact of 1%.
Revenues from the Fire & Safety/Diversified Products segment totaled $179 million, rising 5% year over year. Our estimate for segmental revenues was $175.2 million. The results were aided by a 3% increase in organic sales. Foreign currency translation left a positive impact of 2%.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote
Margin Profile
In the quarter under review, IDEX’s cost of sales decreased 2.8% year over year to $452.1 million. The gross profit was $336.8 million, down 2.6% year over year, while the gross margin was 42.7% compared with 42.6% reported in the year-ago quarter.
Selling, general and administrative expenses increased 2.7% year over year to $173.6 million. Adjusted EBITDA in the quarter under review decreased 7% year over year to $203.6 million. The adjusted EBITDA margin decreased 120 bps year over year to 25.8%.
The operating income was $160.5 million, down 8.3% year over year, whereas the margin was 20.3%, down 130 bps year over year. Interest expenses in the quarter decreased 4.1% year over year to $11.6 million.
Balance Sheet and Cash Flow
While exiting the fourth quarter, IDEX’s cash and cash equivalents were $534.3 million compared with $430.2 million recorded at the end of fourth-quarter 2022. Long-term borrowings were $1.33 billion compared with $1.47 billion recorded at the end of fourth-quarter 2022.
In 2023, IDEX generated net cash of $716.7 million from operating activities, increasing 28.6% from the year-ago period. Capital used for purchasing property, plant and equipment was $89.9 million compared with $68 million in 2022. In 2023, free cash flow was $626.8 million, up 28% year over year.
IEX paid out dividends totaling $190.7 million in 2023, up 7.5% year over year. The company repurchased common stock worth $24.2 million in the quarter.
It spent $311.8 million on acquisitions in 2023.
Outlook
For first-quarter 2024, IDEX anticipates adjusted earnings to be $1.70-$1.75 per share.
On a GAAP basis, IEX predicts earnings to be $1.45-$1.50 per share and a 6-7% decline in organic sales from the respective year-ago readings.
For 2024, IDEX anticipates adjusted earnings to be $8.15-$8.45 per share. The figure represents an increase from $8.22 per share reported in 2023. On a GAAP basis, earnings are predicted to be $7.15-$7.45 per share.
Organic sales are predicted to decline 0-2% in 2024.
Zacks Rank & Other Stocks to Consider
IDEX currently carries a Zacks Rank #2 (Buy).
A few other top-ranked companies from the same space are discussed below:
Parker-Hannifin Corporation (PH - Free Report) presently carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
PH delivered a trailing four-quarter average earnings surprise of 14.4%. In the past 60 days, the Zacks Consensus Estimate for its 2023 earnings has increased 2.7%.
Flowserve Corporation (FLS - Free Report) presently has a Zacks Rank of 2. FLS delivered a trailing four-quarter average earnings surprise of 27.3%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2023 earnings has remained steady.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank #2. It has a trailing four-quarter average earnings surprise of 10.4%. The Zacks
Consensus Estimate for AIT’s fiscal 2024 (ending June 2024) earnings remained steady in the past 60 days.